Genfit S A (GNFT) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2023 and annually, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genfit S a   (NASDAQ: GNFT)

Genfit S A 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Genfit S A in the fourth quarter 2024?
Genfit S a achieved a return on average equity (ROE) of 2.18 % in its fourth quarter 2024, this is above GNFT's average return on equity of -2.24%.
Genfit S A shareholder's equity over the 12 months ending in its fourth quarter 2024 are valued at $78 million

ROE has advanced compared to -41.93% in the third quarter 2024, due to net income growth.

Within the Biotechnology & Pharmaceuticals industry 19 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2316, from total ROE ranking in the third quarter 2024 at 3317.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Equity Change 1.87 % 1.87 % 1.87 % 1.87 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 2 -32 -32 -32 -32
Return On Equity (TTM) 2.18 % -41.93 % -42.13 % -42.32 % -42.52 %
GNFT's Total Ranking # 2316 # 3317 # # #
Equity (TTM) in Millions 78 78 78 78 76
Seq. Equity Change 0 % 0 % 0 % 1.87 % 0 %
Seq. Net Income Change - - - - -

Back to GNFT Management Effectiveness >> GNFT's 5 Years Annual ROE >> Compare GNFT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 20
Sector # 187
Overall # 2316

Return On Equity Statistics
High Average Low
56.47 %
-2.24 %
-42.52 %
(Dec 31 2021)   (Dec 31 2023)





GNFT Annual Return On Equity (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Equity in Millions 78 76 106 133 -18
Y / Y Equity Change 1.87 % -28.12 % -20.63 % - -
Net Income in Millions 2 -32 -27 75 -113
Y / Y Net Income Change - - - - -
Return On Equity 2.18 % -42.52 % -25.09 % 56.47 % -

Back to GNFT Management Effectiveness >> GNFT's 5 Years Annual ROE >> Compare GNFT ROE to its Competitors




Annual Roe Comment
In 2024 ROE improved to 2.18 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GNFT's' Return on Equity at Yahoo Finance
GNFT's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GNFT's Competitors
Subscribers only: Roe for Genfit S A 's Suppliers
Subscribers only: Return On Equity for GNFT's Customers




Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector ROE
Kamada Ltd   5.57 %
Elanco Animal Health Incorporated  5.49 %
The Cooper Companies Inc   5.21 %
American Shared Hospital Services  5.08 %
Hutchmed china Limited  5.02 %
Livanova Plc  4.96 %
Nature s Sunshine Products inc   4.93 %
Docgo Inc   4.90 %
Alcon inc   4.72 %
Fresenius Medical Care Ag  4.70 %
Brainsway Ltd   4.69 %
Dynavax Technologies Corporation  4.30 %
Infusystem Holdings Inc  4.29 %
Lakeland Industries Inc   4.16 %
Vericel Corporation  4.04 %
Vaso Corporation  3.60 %
Ars Pharmaceuticals Inc   3.57 %
Radnet Inc   3.51 %
Revvity Inc  3.45 %
Innoviva Inc   3.43 %
Amedisys Inc  3.25 %
Gilead Sciences Inc   2.62 %
Privia Health Group Inc   2.61 %
Galapagos Nv  2.56 %
Globus Medical Inc   2.55 %
Grifols Sa  2.47 %
Qiagen N v   2.34 %
Genfit S a   2.18 %
Veracyte Inc   2.10 %
Viskase Holdings inc   1.74 %

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.